# MP Materials Corp. / DE: financial statements, quarterly

MP · NYSE · CIK 1801368 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mp.md) · [Financials](/companies/mp/financials.md) · [Filings](/companies/mp/filings.md) · [Insiders](/companies/mp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [52.5](/filings/0001801368-24-000087.md) | [41.2 d](/filings/0001801368-26-000008.md) | [48.7](/filings/0001801368-25-000019.md) | [31.3](/filings/0001801368-25-000028.md) | [62.9](/filings/0001801368-25-000054.md) | [61.0 d](/filings/0001801368-26-000008.md) | [60.8](/filings/0001801368-26-000029.md) | [57.4](/filings/0001801368-26-000048.md) | [53.6](/filings/0001801368-25-000054.md) | [52.7 d](/filings/0001801368-26-000008.md) | [90.6](/filings/0001801368-26-000029.md) | [108](/filings/0001801368-26-000048.md) |
| Selling, general and administrative | $m | [19.6](/filings/0001801368-24-000087.md) | [21.4 d](/filings/0001801368-26-000008.md) | [21.3](/filings/0001801368-25-000019.md) | [21.4](/filings/0001801368-25-000028.md) | [21.5](/filings/0001801368-25-000054.md) | [19.1 d](/filings/0001801368-26-000008.md) | [24.2](/filings/0001801368-26-000029.md) | [27.4](/filings/0001801368-26-000048.md) | [28.4](/filings/0001801368-25-000054.md) | [32.1 d](/filings/0001801368-26-000008.md) | [33.6](/filings/0001801368-26-000029.md) | [35.2](/filings/0001801368-26-000048.md) |
| Operating income | $m | [(17.5)](/filings/0001801368-24-000087.md) | [(33.6) d](/filings/0001801368-26-000008.md) | [(32.4)](/filings/0001801368-25-000019.md) | [(53.5)](/filings/0001801368-25-000028.md) | [(39.5)](/filings/0001801368-25-000054.md) | [(44.0) d](/filings/0001801368-26-000008.md) | [(34.8)](/filings/0001801368-26-000029.md) | [(43.9)](/filings/0001801368-26-000048.md) | [(67.0)](/filings/0001801368-25-000054.md) | [(3.7) d](/filings/0001801368-26-000008.md) | [(24.1)](/filings/0001801368-26-000029.md) | [(32.0)](/filings/0001801368-26-000048.md) |
| Interest expense | $m | [1.4](/filings/0001801368-24-000087.md) | [1.1 d](/filings/0001801368-24-000014.md) | [2.9](/filings/0001801368-25-000019.md) | [6.7](/filings/0001801368-25-000028.md) | [6.6](/filings/0001801368-25-000054.md) | [6.8 d](/filings/0001801368-26-000008.md) | [7.6](/filings/0001801368-26-000029.md) | [5.4](/filings/0001801368-26-000048.md) | [8.6](/filings/0001801368-25-000054.md) | [9.9 d](/filings/0001801368-26-000008.md) | [9.8](/filings/0001801368-26-000029.md) | [9.7](/filings/0001801368-26-000048.md) |
| Income tax | $m | [(0.2)](/filings/0001801368-24-000087.md) | [(4.4) d](/filings/0001801368-26-000008.md) | [7.1](/filings/0001801368-25-000019.md) | [(14.1)](/filings/0001801368-25-000028.md) | [(9.4)](/filings/0001801368-25-000054.md) | [(11.6) d](/filings/0001801368-26-000008.md) | [(4.5)](/filings/0001801368-26-000029.md) | [(11.9)](/filings/0001801368-26-000048.md) | [(16.7)](/filings/0001801368-25-000054.md) | [1.1 d](/filings/0001801368-26-000008.md) | [(5.7)](/filings/0001801368-26-000029.md) | [(9.0)](/filings/0001801368-26-000048.md) |
| Net income | $m | [(4.3)](/filings/0001801368-24-000087.md) | [(16.3) d](/filings/0001801368-26-000008.md) | [16.5](/filings/0001801368-25-000019.md) | [(34.1)](/filings/0001801368-25-000028.md) | [(25.5)](/filings/0001801368-25-000054.md) | [(22.3) d](/filings/0001801368-26-000008.md) | [(22.6)](/filings/0001801368-26-000029.md) | [(30.9)](/filings/0001801368-26-000048.md) | [(41.8)](/filings/0001801368-25-000054.md) | [9.4 d](/filings/0001801368-26-000008.md) | [(8.0)](/filings/0001801368-26-000029.md) | [(20.3)](/filings/0001801368-26-000048.md) |
| Diluted EPS | $ per share | [(0.02)](/filings/0001801368-24-000087.md) | not reported | [(0.08)](/filings/0001801368-25-000019.md) | [(0.21)](/filings/0001801368-25-000028.md) | [(0.16)](/filings/0001801368-25-000054.md) | not reported | [(0.14)](/filings/0001801368-26-000029.md) | [(0.19)](/filings/0001801368-26-000048.md) | [(0.24)](/filings/0001801368-25-000054.md) | not reported | [(0.04)](/filings/0001801368-26-000029.md) | [(0.11)](/filings/0001801368-26-000048.md) |
| Basic EPS | $ per share | [(0.02)](/filings/0001801368-24-000087.md) | not reported | [0.09](/filings/0001801368-25-000019.md) | [(0.21)](/filings/0001801368-25-000028.md) | [(0.16)](/filings/0001801368-25-000054.md) | not reported | [(0.14)](/filings/0001801368-26-000029.md) | [(0.19)](/filings/0001801368-26-000048.md) | [(0.24)](/filings/0001801368-25-000054.md) | not reported | [(0.04)](/filings/0001801368-26-000029.md) | [(0.11)](/filings/0001801368-26-000048.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating, us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [548](/filings/0001801368-24-000087.md) | [263](/filings/0001801368-26-000008.md) | [296](/filings/0001801368-25-000019.md) | [296](/filings/0001801368-25-000028.md) | [284](/filings/0001801368-25-000054.md) | [282](/filings/0001801368-26-000008.md) | [198](/filings/0001801368-26-000029.md) | [262](/filings/0001801368-26-000048.md) | [1,147](/filings/0001801368-25-000054.md) | [1,166](/filings/0001801368-26-000048.md) | [886](/filings/0001801368-26-000029.md) | [429](/filings/0001801368-26-000048.md) |
| Current assets | $m | [1,188](/filings/0001801368-23-000036.md) | [1,131](/filings/0001801368-25-000009.md) | [1,106](/filings/0001801368-24-000045.md) | [1,091](/filings/0001801368-24-000066.md) | [1,017](/filings/0001801368-24-000087.md) | [1,031](/filings/0001801368-26-000008.md) | [1,023](/filings/0001801368-25-000019.md) | [960](/filings/0001801368-25-000028.md) | [2,174](/filings/0001801368-25-000054.md) | [2,166](/filings/0001801368-26-000048.md) | [2,047](/filings/0001801368-26-000029.md) | [1,745](/filings/0001801368-26-000048.md) |
| Total assets | $m | [2,322](/filings/0001801368-23-000036.md) | [2,336](/filings/0001801368-25-000009.md) | [2,354](/filings/0001801368-24-000045.md) | [2,364](/filings/0001801368-24-000066.md) | [2,300](/filings/0001801368-24-000087.md) | [2,334](/filings/0001801368-26-000008.md) | [2,368](/filings/0001801368-25-000019.md) | [2,336](/filings/0001801368-25-000028.md) | [3,798](/filings/0001801368-25-000054.md) | [3,864](/filings/0001801368-26-000048.md) | [3,840](/filings/0001801368-26-000029.md) | [3,727](/filings/0001801368-26-000048.md) |
| Current liabilities | $m | [97.0](/filings/0001801368-23-000036.md) | [109](/filings/0001801368-25-000009.md) | [108](/filings/0001801368-24-000045.md) | [158](/filings/0001801368-24-000066.md) | [147](/filings/0001801368-24-000087.md) | [164](/filings/0001801368-26-000008.md) | [248](/filings/0001801368-25-000019.md) | [267](/filings/0001801368-25-000028.md) | [270](/filings/0001801368-25-000054.md) | [299](/filings/0001801368-26-000048.md) | [285](/filings/0001801368-26-000029.md) | [184](/filings/0001801368-26-000048.md) |
| Total liabilities | $m | [946](/filings/0001801368-23-000036.md) | [971](/filings/0001801368-25-000009.md) | [1,216](/filings/0001801368-24-000045.md) | [1,255](/filings/0001801368-24-000066.md) | [1,236](/filings/0001801368-24-000087.md) | [1,279](/filings/0001801368-26-000008.md) | [1,332](/filings/0001801368-25-000019.md) | [1,326](/filings/0001801368-25-000028.md) | [1,420](/filings/0001801368-25-000054.md) | [1,472](/filings/0001801368-26-000048.md) | [1,459](/filings/0001801368-26-000029.md) | [1,356](/filings/0001801368-26-000048.md) |
| Long-term debt | $m | [681](/filings/0001801368-23-000036.md) | [682](/filings/0001801368-25-000009.md) | [936](/filings/0001801368-24-000045.md) | [937](/filings/0001801368-24-000066.md) | [938](/filings/0001801368-24-000087.md) | [909](/filings/0001801368-26-000008.md) | [842](/filings/0001801368-25-000019.md) | [843](/filings/0001801368-25-000028.md) | [930](/filings/0001801368-25-000054.md) | [931](/filings/0001801368-26-000048.md) | [933](/filings/0001801368-26-000029.md) | [935](/filings/0001801368-26-000048.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001801368-26-000008.md) | [67.3](/filings/0001801368-25-000019.md) | [67.4](/filings/0001801368-25-000028.md) | [67.5](/filings/0001801368-25-000054.md) | [67.4](/filings/0001801368-26-000048.md) | [67.5](/filings/0001801368-26-000029.md) | [0.0](/filings/0001801368-26-000048.md) |
| Shareholders' equity | $m | [1,376](/filings/0001801368-24-000087.md) | [1,366](/filings/0001801368-26-000008.md) | [1,138](/filings/0001801368-25-000028.md) | [1,109](/filings/0001801368-25-000054.md) | [1,065](/filings/0001801368-25-000054.md) | [1,055](/filings/0001801368-26-000048.md) | [1,036](/filings/0001801368-26-000048.md) | [1,011](/filings/0001801368-26-000048.md) | [1,965](/filings/0001801368-25-000054.md) | [1,979](/filings/0001801368-26-000048.md) | [1,967](/filings/0001801368-26-000048.md) | [1,957](/filings/0001801368-26-000048.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [11.0 d](/filings/0001801368-24-000087.md) | [(13.8) d](/filings/0001801368-26-000008.md) | [(41.1)](/filings/0001801368-25-000019.md) | [30.8 d](/filings/0001801368-25-000028.md) | [(6.8) d](/filings/0001801368-25-000054.md) | [30.5 d](/filings/0001801368-26-000008.md) | [(63.2)](/filings/0001801368-26-000029.md) | [(3.7) d](/filings/0001801368-26-000048.md) | [(42.0) d](/filings/0001801368-25-000054.md) | [(46.9) d](/filings/0001801368-26-000008.md) | [(1.9)](/filings/0001801368-26-000029.md) | [6.8 d](/filings/0001801368-26-000048.md) |
| Capital expenditure | $m | [58.7 d](/filings/0001801368-24-000087.md) | [73.0 d](/filings/0001801368-26-000008.md) | [51.8](/filings/0001801368-25-000019.md) | [46.5](/filings/0001801368-25-000028.md) | [46.4](/filings/0001801368-25-000054.md) | [41.7 d](/filings/0001801368-26-000008.md) | [30.5](/filings/0001801368-26-000029.md) | [29.0](/filings/0001801368-26-000048.md) | [50.5](/filings/0001801368-25-000054.md) | [62.4 d](/filings/0001801368-26-000008.md) | [77.4](/filings/0001801368-26-000029.md) | [230](/filings/0001801368-26-000048.md) |
| Share repurchases | $m | [0.0 d](/filings/0001801368-24-000087.md) | [0.0 d](/filings/0001801368-26-000008.md) | [201](/filings/0001801368-25-000019.md) | [0.0 d](/filings/0001801368-25-000028.md) | [24.3](/filings/0001801368-25-000054.md) | [0.0 d](/filings/0001801368-26-000008.md) | [0.0](/filings/0001801368-25-000019.md) | [0.0 d](/filings/0001801368-25-000028.md) | [0.0 d](/filings/0001801368-25-000054.md) | [0.0 d](/filings/0001801368-26-000008.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [193](/filings/0001801368-23-000036.md) | [194](/filings/0001801368-24-000045.md) | [178](/filings/0001801368-24-000066.md) | [177](/filings/0001801368-24-000087.md) | [187](/filings/0001801368-25-000019.md) | [165](/filings/0001801368-25-000028.md) | [164](/filings/0001801368-25-000054.md) | [164](/filings/0001801368-26-000029.md) | [164](/filings/0001801368-26-000048.md) | [175](/filings/0001801368-25-000054.md) | [178](/filings/0001801368-26-000029.md) | [178](/filings/0001801368-26-000048.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 178,101,588 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001801368-26-000048.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.